In current study, we showed that the cell co-culture model which mimicked BM microenvironment protected CML cells from IM treatment by up-regulating the Hh pathway and then the BCR-ABL/PI3K/AKT signaling. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.